ATRA vs VICI · rev $128.9M vs P/E 9.3, rev $3.85B
Atara Biotherapeutics Inc (ATRA) versus VICI Properties Inc (VICI) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
VICI Properties Inc (VICI) is a reit - diversified company listed on NYSE.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported VICI revenue for 2024-12-31 was $3.85B. Net income was $2.72B. Revenue was up 6.6% from 2023-12-31 to 2024-12-31. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
ATRA currently screens at market cap $87.1M. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
Not investment advice. Open the ATRA and VICI stock pages for the full models.
Not investment advice.